Clinical trial
Assessment and Modulation of Cortical Gamma Synchrony to Predict and Improve Stroke Recovery
NCT05830617 is registered in ClinicalTrials.gov with IRCCS San Camillo, Venezia, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment and Modulation of Cortical Gamma Synchrony to Predict and Improve Stroke Recovery
- Lead sponsor
- IRCCS San Camillo, Venezia, Italy
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 23, 2021
- Completion date
- March 23, 2024
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.